Labeler · US market

Glaukos Corporation

Glaukos Corporation is a US drug labeler with US FDA registrations covering 3 drug concepts (2 currently active) across 4 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes25357

Active drugs2

Registrations2 active / 3

Packages4

Sole supplier of2 drugs

Portfolio3 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Travoprost Intracameral implant	rx	1	2	SUPPLYING
Riboflavin 5-Phosphate Ophthalmic kit	rx	1	1	SUPPLYING
Riboflavin 5-Phosphate Ophthalmic kit	rx	1	1	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes25357
Filing names1
Drugs (active)2
Drugs (all time)3
US registrations3
Packages4

Recent events

Shortages, recalls, and registration changes across all filing names.

Jan 20, 2026
RESOLVEDShortage resolved: Riboflavin 5-phosphate Ophthalmic Solution (Glaukos Corporation)
Jan 20, 2026
SHORTAGEDrug shortage: Riboflavin 5-phosphate Ophthalmic Solution (Glaukos Corporation)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.